Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.
about
HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretionEarly Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsTreatment of prediabetesOligomerization of Peptides LVEALYL and RGFFYT and Their Binding Affinity to InsulinType 2 diabetes can be prevented with early pharmacological interventionDietary Interventions for Type 2 Diabetes: How Millet Comes to HelpClass II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cellsInsulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care.Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis StudyLack of racial disparity in incident prediabetes and glycemic progression among black and white offspring of parents with type 2 diabetes: the pathobiology of prediabetes in a biracial cohort (POP-ABC) study.Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein.Defining and characterizing the progression of type 2 diabetes.The Imbalance of B-Lymphocyte Subsets in Subjects with Different Glucose Tolerance: Relationship with Metabolic Parameter and Disease Status.Effects of Synbiotic Food Consumption on Serum Minerals, Liver Enzymes, and Blood Pressure in Patients with Type 2 Diabetes: A Double-blind Randomized Cross-over Controlled Clinical TrialInsulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men.Association of central adiposity with prediabetes and decreased insulin sensitivity in rural Chinese normal-weight and overweight women.DNA methylation of microRNA-375 in impaired glucose toleranceThe impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea.SGLT-2 inhibitors in development for type 2 diabetes treatmentEffect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes.Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trialHigh calorie intake is associated with worsening insulin resistance and β-cell function in Hispanic women after gestational diabetes mellitus.Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.The heritability of beta cell function parameters in a mixed meal test design.Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes.Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission.Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes.Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels.Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis StudyHOMA-IR Values are Associated With Glycemic Control in Japanese Subjects Without Diabetes or Obesity: The KOBE Study.Phylloquinone intake, insulin sensitivity, and glycemic status in men and women.Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention StudyThe management of type 2 diabetic patients with hypoglycemic agentsImpact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose toleranceSimultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious unhandled miceExenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-DiabetesRole of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretionAcute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations.Preventing diabetes in obese Latino youth with prediabetes: a study protocol for a randomized controlled trial.
P2860
Q24299570-4676E5DD-C55F-4681-83D9-B575A907D682Q26767164-6FCD889C-75B7-40A9-8AF4-6927A5105143Q26783350-84F41E40-9B34-431E-8B87-D43D204B55AFQ27316871-9B60361A-49CA-4B3E-A0B3-46CF5D8B5D04Q27694430-A043ADE8-60A3-4E75-8418-E5B19F337E29Q28079718-7A2BB2D5-5919-4D8D-8513-DF63FE1012C2Q28575171-7F475616-3ADD-438A-9A83-3CAF6843CB2DQ33556828-53BFD6DF-194D-49A7-9E22-B9B888BDA339Q33556896-10EABB19-B5E1-493B-825B-E69946B85E58Q33570090-057491F3-58F5-4B11-99DC-06676D60AA5DQ33602322-D789B09A-27BC-49A4-9275-5660B06CF315Q33610728-12F33849-D73E-4557-8875-6DDB397C29DBQ33618986-01B8E573-8420-474A-A527-502E7D6D0961Q33810525-65E711B3-659F-482E-B883-89F9DDA5EB5BQ33854415-BEFBD0D8-3D23-471B-A5B0-3248EAD9B07BQ33901054-C0BC8292-8EAF-4549-A08E-A68ABAFC25ACQ33962117-40549141-F3BA-4F89-BE3F-4F4EAF1107E3Q34227968-5A8AFA9A-9F2F-4516-9B90-0263D869111FQ34248505-DDEC1498-3F0F-4899-87DC-BF63F53FE485Q34424907-4E9F0518-2504-4121-A948-083B45D3E67FQ34527061-F6EEA2B1-6243-4F5C-875E-F6A4A2A44CBEQ34545348-5D71B558-AE8C-4734-881F-CDAC43A24BA1Q34766224-4EC1A298-BEE2-42DE-BBE4-64E8E220322CQ34768527-7595A615-27E8-4A66-BFAE-BDDCD16B0ED9Q35111555-2821CD12-5F3F-4633-8C55-55C51B354015Q35123342-1E9FDCE8-625F-4674-9B1D-40BA55C4A910Q35173918-6DBC4D05-C217-4295-BC4A-20B769B179ECQ35390039-0F40CD6B-9717-40BE-BB5E-EA5A8CC88E9FQ35581227-5D51AE3C-6A20-4604-94E0-857024815898Q35649246-14395B95-E48E-48E5-BABF-919B310EEED4Q35687777-EAF01EFB-4CA3-46F8-A01E-B01D1D774244Q35688277-E0DC7AAE-3F91-4A63-9021-1DB481867CCCQ35909101-B84B285C-9B70-4042-8E18-D350502255FBQ35986206-03AC1252-1474-4702-AE6C-197B2801B476Q36044246-F01CBA43-B1C0-4CAC-A2BA-2FFCDF99B2C0Q36072493-21347518-7845-44F5-89A7-BF7BFAFD349BQ36131766-BF363616-88ED-4126-8916-28F6B507C0EAQ36237838-2FA79BEF-8BBD-4567-AC28-571C2170D863Q36248046-B553F13A-00A3-4C47-9438-ADEB8392BC57Q36311249-3A3847F2-DEDC-495E-B717-F40691446EB7
P2860
Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Insulin resistance and insulin ...... f type 2 diabetes development.
@ast
Insulin resistance and insulin ...... f type 2 diabetes development.
@en
type
label
Insulin resistance and insulin ...... f type 2 diabetes development.
@ast
Insulin resistance and insulin ...... f type 2 diabetes development.
@en
prefLabel
Insulin resistance and insulin ...... f type 2 diabetes development.
@ast
Insulin resistance and insulin ...... f type 2 diabetes development.
@en
P2093
P921
P356
P1433
P1476
Insulin resistance and insulin ...... f type 2 diabetes development.
@en
P2093
Bogardus C
Pratley RE
Tataranni PA
P356
10.2337/DIACARE.24.1.89
P407
P577
2001-01-01T00:00:00Z